T7Y-28653-07769
1 vaccination
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 770 / TX
- Registered
- 2021-02-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Dose 1 — Pfizer-BioNTech
-
2021-02-01
Registered in v-safe
- 2021-02-01
- 2021-02-08
- 2021-02-17
- 2021-02-22
-
2021-04-19
Survey response — 3 months, dose 1MedDRA: Menstrual disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I did not have a menstrual cycle for 75 days after receiving vaccine. I have always had a regular cycle until then.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Report sent to call center — 3 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-30
- 2021-07-25
- 2022-01-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — 3 months, dose 1
Symptoms: I did not have a menstrual cycle for 75 days after receiving vaccine. I have always had a regular cycle until then.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release